Lexeo Therapeutics, Inc. (LXEO) Other Accumulated Expenses (2022 - 2023)
Lexeo Therapeutics' Other Accumulated Expenses history spans 2 years, with the latest figure at $182000.0 for Q3 2023.
- For Q3 2023, Other Accumulated Expenses changed N/A year-over-year to $182000.0; the TTM value through Sep 2023 reached $182000.0, changed N/A, while the annual FY2022 figure was $240000.0, N/A changed from the prior year.
- Other Accumulated Expenses for Q3 2023 was $182000.0 at Lexeo Therapeutics, down from $240000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $240000.0 in Q4 2022 and bottomed at $182000.0 in Q3 2023.